Skip to content
akaturk Academic measurement
2025 SJR Q2 JCR Q2 · 2,9 10 matched articles ESCI

Journal detail

High Blood Pressure and Cardiovascular Prevention

Country
Switzerland · Western Europe
Type
journal
ISSN
  • 11209879
  • 11791985
Scopus 0,824 SJR
Scopus Q2 SJR Q
WoS Q2 JCR Q
WoS 2,9 JIF
Scopus 40 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,824
  • Quartile Q2
  • H-Index 40
  • Cites/doc 2,89
  • Docs (3y) 187
  • Cites (3y) 545

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q2
  • JIF 2,9
  • 5Y JIF 2,8
  • JCI 0,57

WoS indexes

  • ESCI

Subject classification

Categories (SJR)

  • Cardiology and Cardiovascular Medicine Q2
  • Internal Medicine Q2

Areas

  • Medicine

WoS categories

  • Peripheral Vascular Diseases

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q2 Q2 0,824 2,9 2,8 0,57 Q3 40
2024 Q2 Q2 0,893 2,9 2,7 0,68 Q2 37
2023 Q2 Q2 0,69 3,1 2,8 0,62 Q2 37
2022 Q2 — 0,72 3 2,4 0,54 Q2 37
2021 Q2 — 0,749 — — 0,48 Q3 37
2020 Q2 — 0,624 — — 0,46 Q3 37
2019 Q3 — 0,509 — — — — 37
2017 Q2 — 0,524 — — — — 37
2016 Q3 — 0,406 — — — — 37
2015 Q3 — 0,434 — — — — 37
2014 Q3 — 0,382 — — — — 37
2013 Q3 — 0,275 — — — — 37
2012 Q3 — 0,221 — — — — 37
2011 Q3 — 0,168 — — — — 37
2010 Q3 — 0,168 — — — — 37

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 PERIPHERAL VASCULAR DISEASE ESCI Q2 Q3 43/100
2024 PERIPHERAL VASCULAR DISEASE ESCI Q2 Q2 34/98
2023 PERIPHERAL VASCULAR DISEASE ESCI Q2 Q2 27/96
2022 PERIPHERAL VASCULAR DISEASE ESCI — Q2 —
2021 PERIPHERAL VASCULAR DISEASE ESCI — Q3 —
2020 PERIPHERAL VASCULAR DISEASE ESCI — Q3 —